| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Apr―10 |
Prevalence and risk factors of COVID-19 co-infection in TB patients |
T. Nyamsaikhan, G. Dorj, O. Erdenee, B. Jantsansengee, B. Badamnachin, G. Ochirdorj |
| 2 |
[GO] |
2024―Oct―08 |
Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes |
S.J.W. Kang, G.W. Eather, F. Qureshi, J.R. Scott |
| 3 |
[GO] |
2024―Aug―08 |
Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19 |
M. Bastard, D. Falzon, S. Bertagnolio, R. Silva, S.S. Thwin, C. Siquiera Boccolini, et al. (+3) J. Rylance, J. Diaz, M. Zignol |
| 4 |
[GO] |
2024―Jul―18 |
Severe outcomes among adults with TB during COVID-19 |
T. Jacobs, E. Morden, M. Smith, A. von Delft, R. Kassanjee, V. Mudaly, et al. (+2) A. Boulle, M-A. Davies |
| 5 |
[GO] |
2024―Jul―18 |
Healthcare-seeking behavior among people with HIV undergoing TB screening during the COVID-19 pandemic |
I. Aggarwal, L.H. Chaisson, B. Opira, D.W. Dowdy, P.P.J. Phillips, F.C. Semitala, C. Yoon |
| 6 |
[GO] |
2024―Jun―14 |
The impact of the COVID-19 pandemic on TB notifications in Ukraine in 2020 |
A.N. Shapiro, M. Dolynska, S.S. Chiang, N. Rybak, V. Petrenko, C.R. Horsburgh, et al. (+4) J. Kobe, I. Terleieva, O. Sakalska, H.E. Jenkins |
| 7 |
[GO] |
2024―Jan―16 |
Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa |
C. Bekker, I. Dewandel, A. Redfern, C. McKenzie, J. Lishman, L.M. Verhagen, et al. (+9) M. Claassen, S. Wilson, R. Dunbar, C. Bosch, G. van Zyl, W. Preiser, P. Goussard, H. Rabie, M.M. van der Zalm |
|
